Jones SM, Kim EH, Nadeau KC, Nowak-Wegrzyn A, et al. Efficacy and safety of oral immunotherapy in children aged 1-3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study. Lancet 2022;399:359-371.
PMID: 35065784